Related Experiment Video

Updated: Aug 8, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Mediastinal mature teratoma with an immature component--what about the treatment?

E Romagnani, E Gallerani, F Cavalli

    Annals of Oncology : Official Journal of the European Society for Medical Oncology
    |May 27, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Teratoma Generation in the Testis Capsule
    05:24

    Teratoma Generation in the Testis Capsule

    Published on: November 7, 2011

    Related Experiment Videos

    Last Updated: Aug 8, 2026

    Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
    05:08

    Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

    Published on: February 17, 2019

    Teratoma Generation in the Testis Capsule
    05:24

    Teratoma Generation in the Testis Capsule

    Published on: November 7, 2011

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

    Articles linked to this work by shared authors, journal, and citation graph.

    Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).

    Annals of oncology : official journal of the European Society for Medical Oncology·2025

    Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence.

    Critical reviews in oncology/hematology·2023

    Clinical characteristics of vulnerable populations hospitalized and diagnosed with COVID-19 in Buenos Aires, Argentina.

    Scientific reports·2021

    Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers.

    Breast (Edinburgh, Scotland)·2019

    Agents' beliefs and economic regimes polarization in interacting markets.

    Chaos (Woodbury, N.Y.)·2018

    Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017

    Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Thymic radiation is associated with worse outcomes in patients with NSCLC.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2-associated high-risk HER2-negative early breast cancer: updated results from the OlympiA phase III trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026

    ATI-2341 TFA promotes acquisition of epithelial-like immunophenotype in bone marrow mesenchymal stem cells and alleviates intrauterine adhesion in a rat model.

    Pakistan journal of pharmaceutical sciences·2026

    Great saphenous vein arterialisation as a novel technique of vascular conduit preparation for an elective repair of a brachial artery aneurysm.

    The journal of vascular access·2026

    Identification of candidate receptors mediating the osteoanabolic influence of Wnt1.

    JBMR plus·2026

    Bioprinting functional fat - adipocytes as the next frontier in tissue engineering, regenerative medicine, and cultivated meat.

    Frontiers in bioengineering and biotechnology·2026

    Decellularized Fetal Porcine Dermis as a Substrate for Skin Models.

    Artificial organs·2026

    New insights into the role of TWIST1 in breast cancer progression and metastasis.

    Mutation research. Reviews in mutation research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us